National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer.

IF 2.1 Q3 ONCOLOGY

International Journal of Particle Therapy Pub Date : 2021-06-25 eCollection Date: 2021-01-01 DOI:10.14338/IJPT-20-00089.1

Johannes A Langendijk, Frank J P Hoebers, Martin A de Jong, Patricia Doornaert, Chris H J Terhaard, Roel J H M Steenbakkers, Olga Hamming-Vrieze, Jeroen B van de Kamer, Wilko F A R Verbakel, Fatma Keskin-Cambay, Johannes B Reitsma, Arjen van der Schaaf, Liesbeth J Boersma, Ewoud Schuit

{"title":"National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer.","authors":"Johannes A Langendijk, Frank J P Hoebers, Martin A de Jong, Patricia Doornaert, Chris H J Terhaard, Roel J H M Steenbakkers, Olga Hamming-Vrieze, Jeroen B van de Kamer, Wilko F A R Verbakel, Fatma Keskin-Cambay, Johannes B Reitsma, Arjen van der Schaaf, Liesbeth J Boersma, Ewoud Schuit","doi":"10.14338/IJPT-20-00089.1","DOIUrl":null,"url":null,"abstract":"<p><p>In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.</p>","PeriodicalId":36923,"journal":{"name":"International Journal of Particle Therapy","volume":" ","pages":"354-365"},"PeriodicalIF":2.1000,"publicationDate":"2021-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270079/pdf/","citationCount":"26","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Particle Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14338/IJPT-20-00089.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 26

Abstract

In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.

Abstract Image

查看原文本刊更多论文

国家头颈癌质子治疗模型选择方案。

在荷兰，基于模型的方法被用于识别头颈癌患者，与光子治疗相比，质子治疗在预防晚期辐射引起的副作用方面可能受益最多。为此，制定了一项头颈癌患者质子治疗的国家适应症方案(NIPP-HNC)，该方案已得到卫生保健当局的批准。当患者符合NIPP-HNC指南时，质子治疗可全额报销。本文描述了开发这种NIPP-HNC所遵循的程序，并提供了将头颈癌患者基于模型的选择引入常规临床实践的所有必要信息。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊